THE NOVEL BILIRUBIN PHENOL UDP-GLUCURONOSYLTRANSFERASE UGT1 GENE LOCUS - IMPLICATIONS FOR MULTIPLE NONHEMOLYTIC FAMILIAL HYPERBILIRUBINEMIA PHENOTYPES

被引:74
作者
OWENS, IS
RITTER, JK
机构
[1] Section of Genetic Disorders of Drug Metabolism, Human Genetics Branch, National Institute of Child Health and Human Development, Bethesda, MD, 20892
来源
PHARMACOGENETICS | 1992年 / 2卷 / 03期
关键词
D O I
10.1097/00008571-199206000-00001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
At least three types of congenital nonhemolytic unconjugated hyperbilirubinemias, including the rare Crigler-Najjar (CN) diseases (Types I or II) and Gilbert's syndrome (affecting 6% of the population) are associated with either absent or reduced hepatic UDP-glucuronosyltransferase (transferase) activity towards the potentially toxic endogenous acceptor, bilirubin. Here, we review the biochemical studies associated with these deficiencies. Accumulated evidence from studies with an animal model of CN Type I syndrome, the Gunn strain of hyperbilirubinemic rats, suggested that multiple isozymes are absent. These confounding observations have been clarified by a flurry of reports which have revealed the molecular basis for the complex disease phenotype in the Gunn rat and by the isolation and description of a novel human gene complex, UGT1, which encodes multiple and independently-regulated transferase isozymes that contain identical carboxyl terminal regions (246 amino acids). Finally, we discuss the implications of the gene organization and genetic defects determined for four different CN Type I individuals as a basis for a model which explains the inheritance pattern and genotypes of other familial unconjugated hyperbilirubinemias.
引用
收藏
页码:93 / 108
页数:16
相关论文
共 86 条
[1]  
Aitio A., Parkki M.G., Marniemi J., Different effects of 2,3,7,8-tetra- chlorodibenzo-p-dioxin on glucuronide conjugation of various aglycones: Studies in Wistar and Gunn rats, Toxicol Appl Pharmacol, 47, pp. 55-60, (1979)
[2]  
Arias I.M., Gartner L.M., Cohen M., Ben Ezzer J., Levi A.J., Chronic nonhemolytic unconjugated hyperbilirubinemia with glu- curonyl transferase deficiency: Clinical, biochemical, pharmacologic, and genetic evidence for heterogeneity, Am J Med, 47, pp. 395-409, (1969)
[3]  
Axelrod J., Schmid R., Hammaker L., A biochemical lesion in congenital non-obstructive, non-hemolytic jaundice, Nature, 180, pp. 1426-1427, (1957)
[4]  
Bailey A., Robinson D., Dawson A.M., Does Gilbert’s disease exist?, Lancet, 1, pp. 931-933, (1977)
[5]  
Billing B.H., Cole P.G., Lathe G.H., The excretion of bilirubin as diglucuronide giving the direct van den Bergh reaction, Biochem J, 65, pp. 774-784, (1957)
[6]  
Billing B.H., Gray C.H., Kulczycka A., Manfield P., Nicholson D.C., Metabolism of Cl 4-bilirubin in congenital nonhemolytic hyperbilirubinemia, Clin Sci, 27, (1964)
[7]  
Black M., Billing B.H., Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease and Gilbert’s disease, N Engl J Med, 280, pp. 1266-1271, (1969)
[8]  
Black M., Sherlock S., Treatment of Gilbert’s Syndrome with phenobarbitone, Lancet, 1, pp. 1359-1362, (1970)
[9]  
Blanckaert N., Analysis of bilirubin and bilirubin mono- and di-conjugates, Biochem J, 185, pp. 115-128, (1980)
[10]  
Bock K.W., Frohling W., Remmer H., Rexer B., Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase, Biochim Biophys Acta, 327, pp. 46-56, (1973)